Improved Survival of Leukemic Mice Treated with Sodium Caseinate in Combination with Daunorubicin without Toxicity

In recent years, low doses of chemotherapy have been resumed and explored for the treatment of acute myeloid leukemia. Thus, CPX-351, a dual-drug liposomal encapsulation of cytarabine and daunorubicin, was approved by the US Food and Drug Administration, to deliver a synergistic 5 : 1 molar drug rat...

Descripción completa

Detalles Bibliográficos
Autores principales: Aguiñiga-Sánchez, Itzen, Meléndez-Ibarra, Frida Montserrat, Ledesma-Martínez, Edgar, Weiss-Steider, Benny, Fajardo-Orduña, Guadalupe Rosario, Rangel-Corona, Rosalva, García-Gervasio, Sac-Nicte, Ramírez-Padilla, María Guadalupe, Lara-Castañeda, José Luis, Santiago-Osorio, Edelmiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937462/
https://www.ncbi.nlm.nih.gov/pubmed/33727925
http://dx.doi.org/10.1155/2021/6635650

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937462/
https://www.ncbi.nlm.nih.gov/pubmed/33727925
http://dx.doi.org/10.1155/2021/6635650

Ejemplares similares